Kosice, Czechoslovakia

Viera Danielisova

This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Aktiengesellschaft. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Viera Danielisova. Retrieved from https://idiyas.com/inventor/viera-danielisova

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Viera Danielisova: Innovator in Vascular Surgery

Introduction

Viera Danielisova is a notable inventor based in Kosice, CS. He has made significant contributions to the field of vascular surgery through his innovative research and development of pharmaceuticals.

Latest Patents

Danielisova holds a patent for the "Use of 1-(5-oxohexyl)-3-methyl-7-n-propylxanthine in vascular surgery." This patent discloses the use of 1-(5-oxohexyl)-3-methyl-7-n-propylxanthine or its physiologically tolerated salts for the preparation of pharmaceuticals aimed at the prophylaxis and treatment of nerve damage following the interruption of blood circulation. He has 1 patent to his name.

Career Highlights

Viera Danielisova is associated with Hoechst Aktiengesellschaft, a company known for its advancements in pharmaceuticals and healthcare. His work has been instrumental in developing solutions that address critical medical challenges.

Collaborations

Throughout his career, Danielisova has collaborated with esteemed colleagues, including Ralf Kolvenbach and Hans-Peter Schubert. These partnerships have further enhanced the impact of his research in the medical field.

Conclusion

Viera Danielisova's contributions to vascular surgery through his innovative patent demonstrate his commitment to advancing medical science. His work continues to influence the development of effective treatments for nerve damage.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…